Coagulopathy from drugs that inhibit the VKOR, but not vitamin K, can be rescued by administering vitamin K. So, it may be that azvudine inhibited VKOR and played a synergistic anticoagulant effect with rivaroxaban, but this evidence needs to be confirmed in further studies. This evidence concerns the gene VKORC1 and blood coagulation disease.